Of note - Phil mentions the preclinical clear cell renal cell carcinoma work will also be conducted by the University of Newcastle (with different researchers) and further details will be forthcoming.
- Forums
- ASX - By Stock
- RAC
- RAC media coverage
RAC
racura oncology ltd
Add to My Watchlist
5.73%
!
$2.14
RAC media coverage, page-52
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.